NITRIC OXIDE AND MYOCARDIAL REMODELING IN ARTERIAL HYPERTENSION IN AREAS OF HIGHER ALTITUDES

Material and methods. In high altitudes of Elbrus areas we studied 170 person at the age 37-68 y.o.: 110 patients with AH of various grade and 60 healthy persons. All patients underwent general clinical, instrumental and laboratory investigations. Production of NO was assessed by nitrite- anion NO₂^- and nitrate-anion NO₃^- concentration in plasma and erythrocytes by spectral method.

Results. Myocardial geometry changes were found in 53% patients with AH, related to the changes of NO metabolites concentration in blood and hemodynamics. NO concentration was decreased by 5% in patients with AH with normal geometry of the LV. Significant decrease of NO was found in the groups of patients with concentric remodeling of the LV and concentric hypertrophy of the LV by 39% and 92%, respectively. Normal production of NO with higher concentration of nitrites in the blood was found in patients with eccentric hypertrophy.

Conclusion. In total, the data shows a significant role of NO for the regulation of blood pressure and course of the LV remodeling in AH patients. Under conditions of chronic hypoxia production of NO increases, and that might influence significantly hemodynamics and types of the left ventricle geometry in higher altitudes inhabitants. 

1. Jugdutt BI, Dhalla NS. Cardiac remodeling: molecular mechanisms. Springer: London 2013: 121-343.

2. Nadruz W. Myocardial remodeling in hypertension. J Hum Hypertens 2015; 29: 1-6.

3. Frohlich ED, Susic D, Pressure overload. Heart Failure Clin 2012; 8: 21-32.

4. Gonzalez A, Lopez B, Ravassa S, et al. Biochemical markers of myocardial remodeling in hypertensive heart disease. Cardiovasc Res 2009; 81: 509-18.

5. Lupinskaja ZA, Zarif'jan AG, Gurovich TC, Shlejfer SG. Endothelium: function and dysfunction. Barys.: KRSU im. B. N. El'cina. 2008; 373p: 33-321. Russian (Лупинская З.А., Зарифьян А. Г., Гурович Т. Ц., Шлейфер С. Г. Эндотелий. Функция и дисфункция. Барыс.: КРСУ им. Б.Н. Ельцина 2008: 33-321).

6. Bian K, Doursout MF, Murad F. Vascular system: Role of nitric oxide in cardiovascular diseases. J Clin Hypertens 2008; 10: 304-10.

7. Narayan J, Ghildiyal A, Goyal M, et al. Cold pressor response in High Landers versus Low Landers. J Clin and Diag Research 2014; 8(10): BC08-11.

8. Erzurum SC, Ghosh S, Janocha AJ, et al. Higher blood flow and circulating NO products offset high-altitude hypoxia among Tibetans. Proc Natl Acad Sci USA 2007; 104(45): 17593-8.

9. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of

10. Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertension 2013; 31(7): 1281-357; 1284-340.

11. Rybakova MK, Alehin MN, Mit'kov VV. Practical guidance on ultrasonic diagnostics. Eehokardiografija. M.: Izdatel'skij dom Vidar-M 2008: 53-69. Russian (Рыбакова М. К., Алехин М.Н., Митьков В. В. Практическое руководство по ультразвуковой диагностике. Эхокардиография. М.: Издательский дом Видар-М 2008: 53-69).

12. Nechesova TA, Korobko IJu, Kuznecova NI. Left ventricular remodeling: pathogens and estimation methods. Medicinskie novosti 2008; 11: 7-13. Russian (Нечесова Т. А., Коробко И. Ю., Кузнецова Н. И. Ремоделирование левого желудочка: патогенез и методы оценки. Медицинские новости 2008;11: 7-13).

13. Tsikas D. Methods of quantitative analysis of the nitric oxide metabolites nitrite and nitrate in human biological liquids. Free Radic Res 2005; 39(8): 797-815.

14. Feihl1 F, Liaudet L, Levy BI, Waeber B. Hypertension and micro-vascular remodeling. Cardiovascular Res 2008; 78: 274-85; 277-83.

15. Kovaleva ON, Nizhegorodceva OA. Nitric oxide system condition at formations hypertensive heart. Ukrains'kii kardiologichnii zhurnal 2003; 3: 71-5. Russian (Ковалева О. Н., Нижегородцева О.А. Состояние системы оксида азота при формировании гипертензивного сердца. Украіннський кардюлопчний журнал 2003; 3: 71-5).

16. Drazner МК The progression of hypertensive heart disease. Circulation 2011; 123: 327-34.